World's Best Scientists 2026 revealed!
Tetsuya Mitsudomi

Tetsuya Mitsudomi

Award Badge
Medicine
Japan
2023

D-Index & Metrics

Medicine

D-Index
128
Citations
76607
World Ranking
2666
National Ranking
48

Research.com Recognitions

  • 2023 - Research.com Medicine in Japan Leader Award

Overview

Tetsuya Mitsudomi is affiliated with Kindai University in Japan and has an extensive research portfolio primarily within the field of Medicine, with a notable focus on Pulmonary and Respiratory Medicine. Their work covers a range of subfields including Oncology, Molecular Biology, Cancer Research, and Radiology, Nuclear Medicine and Imaging. Mitsudomi's research topics largely center on lung cancer, including treatment, diagnosis, mutations, and cancer immunotherapy.

Their main topics of study include:

  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Cancer Immunotherapy and Biomarkers
  • Lung Cancer Research Studies
  • Cancer Genomics and Diagnostics
  • Radiomics and Machine Learning in Medical Imaging
  • HER2/EGFR in Cancer Research

Mitsudomi has been published in a variety of well-regarded scientific journals. Frequent publication venues include:

  • Journal of Thoracic Oncology
  • Journal of Clinical Oncology
  • Lung Cancer
  • Translational Lung Cancer Research
  • JTO Clinical and Research Reports

Their research collaborations have involved several frequent co-authors including:

  • Kenichi Suda
  • Junichi Soh
  • Shuta Ohara
  • Akira Hamada
  • Toshio Fujino

A selection of recent papers authored or co-authored by Mitsudomi includes:

  • Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial (2022, The Lancet)
  • Liquid Biopsy for Advanced NSCLC: A Consensus Statement From the International Association for the Study of Lung Cancer (2021, Journal of Thoracic Oncology)
  • Perioperative Durvalumab for Resectable Non-Small-Cell Lung Cancer (2023, New England Journal of Medicine)
  • IASLC Multidisciplinary Recommendations for Pathologic Assessment of Lung Cancer Resection Specimens After Neoadjuvant Therapy (2020, Journal of Thoracic Oncology)
  • A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer (2020, Journal of Thoracic and Cardiovascular Surgery)

Best Publications

  • International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma

    William D Travis;Elisabeth Brambilla;Masayuki Noguchi;Andrew G Nicholson

  • MET Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling

    Jeffrey A. Engelman;Kreshnik Zejnullahu;Tetsuya Mitsudomi;Youngchul Song

  • Gefitinib versus cisplatin plus docetaxel in patients with non-small-cell lung cancer harbouring mutations of the epidermal growth factor receptor (WJTOG3405): an open label, randomised phase 3 trial

    Tetsuya Mitsudomi;Satoshi Morita;Yasushi Yatabe;Shunichi Negoro

  • Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival

    Junichi Takamizawa;Hiroyuki Konishi;Kiyoshi Yanagisawa;Shuta Tomida

  • Mutations of the Epidermal Growth Factor Receptor Gene in Lung Cancer Biological and Clinical Implications

    Takayuki Kosaka;Yasushi Yatabe;Hideki Endoh;Hiroyuki Kuwano

  • EML4-ALK Mutations in Lung Cancer That Confer Resistance to ALK Inhibitors

    Young Lim Choi;Manabu Soda;Yoshihiro Yamashita;Toshihide Ueno

  • Increased Expression of Cyclooxygenase 2 Occurs Frequently in Human Lung Cancers, Specifically in Adenocarcinomas

    Toyoaki Hida;Yasushi Yatabe;Hiroyuki Achiwa;Hideki Muramatsu

  • Mutations of the Epidermal Growth Factor Receptor Gene Predict Prolonged Survival After Gefitinib Treatment in Patients With Non–Small-Cell Lung Cancer With Postoperative Recurrence

    Tetsuya Mitsudomi;Takayuki Kosaka;Hideki Endoh;Yoshitsugu Horio

  • Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

    Toyoaki Hida;Hiroshi Nokihara;Masashi Kondo;Young Hak Kim

  • Reduced expression of Dicer associated with poor prognosis in lung cancer patients.

    Yoko Karube;Hisaaki Tanaka;Hisaaki Tanaka;Hirotaka Osada;Shuta Tomida

  • Hepatocyte Growth Factor Induces Gefitinib Resistance of Lung Adenocarcinoma with Epidermal Growth Factor Receptor–Activating Mutations

    Seiji Yano;Wei Wang;Qi Li;Kunio Matsumoto

  • Analysis of Epidermal Growth Factor Receptor Gene Mutation in Patients with Non–Small Cell Lung Cancer and Acquired Resistance to Gefitinib

    Takayuki Kosaka;Yasushi Yatabe;Hideki Endoh;Kimihide Yoshida

  • Mutations of the epidermal growth factor receptor gene and related genes as determinants of epidermal growth factor receptor tyrosine kinase inhibitors sensitivity in lung cancer.

    Tetsuya Mitsudomi;Yasushi Yatabe

  • A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201).

    Kenji Suzuki;Teruaki Koike;Takashi Asakawa;Masahiko Kusumoto

  • Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancer

    Tetsuya Mitsudomi;Yasushi Yatabe

  • Mutations in the p53 gene are frequent in primary, resected non-small cell lung cancer. Lung Cancer Study Group.

    Chiba I;Takahashi T;Nau Mm;D'Amico D

  • Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study

    Glenwood Goss;Chun-Ming Tsai;Frances A Shepherd;Lyudmila Bazhenova

  • p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.

    T Mitsudomi;S M Steinberg;M M Nau;D Carbone

  • Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial

    Johan F. Vansteenkiste;Byoung Chul Cho;Tonu Vanakesa;Tommaso De Pas

  • Cyclooxygenase-2 Inhibitor Induces Apoptosis and Enhances Cytotoxicity of Various Anticancer Agents in Non-Small Cell Lung Cancer Cell Lines

    Toyoaki Hida;Ken-ichi Kozaki;Hideki Muramatsu;Akira Masuda

Frequent Co-Authors

Yasushi Yatabe
Yasushi Yatabe Nagoya University
Takashi Takahashi
Takashi Takahashi Nagoya University
Kazuhiko Nakagawa
Kazuhiko Nakagawa Kindai University
Keitaro Matsuo
Keitaro Matsuo Nagoya University
Kazuto Nishio
Kazuto Nishio Kindai University
Shinichi Toyooka
Shinichi Toyooka Okayama University
Hiroyuki Kuwano
Hiroyuki Kuwano Gunma University
Isamu Okamoto
Isamu Okamoto Kyushu University
Keizo Sugimachi
Keizo Sugimachi Kyushu University
Hisao Asamura
Hisao Asamura Keio University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re interested in expanding your healthcare knowledge or looking for alternative routes into medicine, several online degree options can help you advance your career. For registered nurses wanting to become nurse practitioners, adn to np bridge programs offer a flexible path to advanced practice without putting your life on hold.

Nutrition is a key part of holistic healthcare, and an online nutrition degree can prepare you for roles in wellness, research, or clinical settings. For those aiming to enter healthcare leadership, pursuing a cahme accredited online mha ensures a rigorous, reputable education in healthcare administration.

Additionally, nurses who want to advance while balancing work can consider rn bsn online programs no clinicals. These programs offer theoretical depth with minimal on-site requirements.

Online degrees in the health sciences are growing in popularity, offering convenience, accreditation, and pathways to a variety of rewarding careers. Explore these options to find the best fit for your professional goals.

Best Scientists Citing Tetsuya Mitsudomi

Trending Scientists

Recently Published Articles